| St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Gabapentin (NCT04052139) | Boston Medical Center | 2021-01-25 |
| The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial) (NCT04712279) | Corpometria Institute | 2021-01-25 |
| BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) (NCT04752826) | BioInvent International AB | 2021-01-25 |
| COVID-19 Study of Safety and Tolerability of Alvelestat (NCT04539795) | University of Alabama at Birmingham | 2021-01-25 |
| Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention (NCT04375813) | Robert Svatek | 2021-01-25 |
| Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies (NCT04640246) | Taiga Biotechnologies, Inc. | 2021-01-25 |
| Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL) (NCT04611880) | Washington University School of Medicine | 2021-01-25 |
| A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis (NCT04697056) | Vanda Pharmaceuticals | 2021-01-25 |
| Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies (NCT04195633) | Fred Hutchinson Cancer Center | 2021-01-25 |
| Tofacitinib For Treatment Of Chronic Pouchitis (NCT04580277) | Cedars-Sinai Medical Center | 2021-01-25 |
| Isatuximab in Combination With Novel Agents in RRMM - Master Protocol (NCT04643002) | Sanofi | 2021-01-25 |
| Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (NCT04718415) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-01-23 |
| Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer (NCT04496219) | Fred Hutchinson Cancer Center | 2021-01-22 |
| Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors (NCT04911907) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2021-01-22 |
| Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients. (NCT05172050) | Dompé Farmaceutici S.p.A | 2021-01-22 |
| Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer (NCT04739566) | Saint Petersburg State University, Russia | 2021-01-22 |
| A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease (NCT04592874) | Alector Inc. | 2021-01-22 |
| A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment (NCT04563026) | Durect | 2021-01-22 |
| Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma (NCT04714827) | Shanxi Province Cancer Hospital | 2021-01-22 |
| Rho Kinase (ROCK) Inhibitor in Tauopathies - 1 (NCT04734379) | Woolsey Pharmaceuticals | 2021-01-22 |
| A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain (NCT04641273) | Bayer | 2021-01-22 |
| Prebiotic Galacto-oligosaccharide and Acute GVHD (NCT04373057) | University of Kansas Medical Center | 2021-01-22 |
| A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children (NCT04750902) | Colgate Palmolive | 2021-01-21 |
| Remotely Administered Diet Intervention to Impact Symptom Burden in Myeloproliferative Neoplasm (NCT04744974) | University of California, Irvine | 2021-01-21 |
| A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC (NCT04982549) | Shandong Cancer Hospital and Institute | 2021-01-21 |
| Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe) (NCT04942730) | St. Petersburg State Pavlov Medical University | 2021-01-21 |
| Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (NCT03851081) | Roswell Park Cancer Institute | 2021-01-21 |
| Haploidentical HCT for Severe Aplastic Anemia (NCT04558736) | St. Jude Children's Research Hospital | 2021-01-21 |
| CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT04633278) | Regeneron Pharmaceuticals | 2021-01-21 |
| Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies (NCT04943757) | St. Petersburg State Pavlov Medical University | 2021-01-21 |
| Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19) (NCT04668209) | University of Arizona | 2021-01-21 |
| Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease (NCT04713631) | Sanjay Gandhi Postgraduate Institute of Medical Sciences | 2021-01-21 |
| Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19. (NCT04951349) | Turn Therapeutics | 2021-01-21 |
| The DART Study- Daratumumab Treatment in ITP (NCT04703621) | Ostfold Hospital Trust | 2021-01-21 |
| Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers (NCT04251819) | University of Alabama at Birmingham | 2021-01-21 |
| Detection of Acetylsalicylic Acid and Omega-3 Fatty Acids in Schirmers' Test Strips Using Mass Spectrometry (NCT05775536) | Medical University of Vienna | 2021-01-21 |
| Optimization for Regorafenib in HCC (NCT04476329) | SC Liver Research Consortium, LLC | 2021-01-21 |
| Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE) (NCT04733040) | HI-Bio, A Biogen Company | 2021-01-20 |
| A Study of TQ-B3525 in Subjects With Relapse/Refractory Diffuse Large B-cell Lymphoma （DLBCL） (NCT04610970) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-01-20 |
| Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors (NCT04669496) | Shanghai Zhongshan Hospital | 2021-01-20 |
| Clinical and Radiographic Assessment of Partial and Complete Pulpotomy in Primary Molars Using MTA (NCT04650113) | Cairo University | 2021-01-20 |
| Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer (NCT04702009) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-01-20 |
| Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19) (NCT04931238) | Peking Union Medical College Hospital | 2021-01-20 |
| Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19) (NCT04742738) | SK Bioscience Co., Ltd. | 2021-01-20 |
| Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer (NCT04544189) | Novartis Pharmaceuticals | 2021-01-20 |
| Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma (NCT04443010) | Philogen S.p.A. | 2021-01-20 |
| The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer (NCT04671407) | Kaplan Medical Center | 2021-01-20 |
| Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer (NCT04408924) | Eli Lilly and Company | 2021-01-20 |
| Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing (NCT05344248) | Shanghai Junshi Bioscience Co., Ltd. | 2021-01-20 |
| Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke (NCT04280003) | Instituto de Investigación Hospital Universitario La Paz | 2021-01-20 |
| A Study of AZD8233 in Participants With Dyslipidemia. (NCT04823611) | AstraZeneca | 2021-01-20 |
| Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer (NCT04511026) | Stanford University | 2021-01-20 |
| Positioning Imatinib for Pulmonary Arterial Hypertension (NCT04416750) | Imperial College London | 2021-01-20 |
| An Open Label Study of the Effects of SHR1459 in NMOSDs Patients (NCT04670770) | Reistone Biopharma Company Limited | 2021-01-20 |
| A Pilot Trial to Determine the Effective N-acetylcysteine Dose for Opioid Reduction for Spine Surgery. (NCT04562597) | Medical University of South Carolina | 2021-01-20 |
| 68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours (NCT06155994) | Medical University Innsbruck | 2021-01-20 |
| Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors (NCT04771520) | M.D. Anderson Cancer Center | 2021-01-20 |
| Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19 (NCT04716569) | South Valley University | 2021-01-20 |
| A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents. (NCT05137067) | Optimal Health Research | 2021-01-20 |
| Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT04922450) | Hunan Cancer Hospital | 2021-01-20 |
| An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome (NCT04740476) | Stoke Therapeutics, Inc | 2021-01-20 |
| Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19 (NCT04964583) | Coordinación de Investigación en Salud, Mexico | 2021-01-20 |
| E-cigarette Nicotine Study (NCT04709471) | University of Vermont | 2021-01-20 |
| Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) (NCT04564339) | Alexion Pharmaceuticals, Inc. | 2021-01-19 |
| Rimegepant in Moderate Plaque-type Psoriasis (NCT04629950) | Weill Medical College of Cornell University | 2021-01-19 |
| The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease (NCT05460546) | Beijing Konruns Pharmaceutical Co., Ltd. | 2021-01-19 |
| Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA® (NCT05163535) | Viriom | 2021-01-19 |
| Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19 (NCT04724720) | Northwell Health | 2021-01-19 |
| Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer (NCT04717154) | Radboud University Medical Center | 2021-01-19 |
| Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain (NCT04778592) | Eliem Therapeutics (UK) Ltd. | 2021-01-19 |
| A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors (NCT04612712) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2021-01-19 |
| Εffectiveness of Intrauterine Antibiotic Administration for Treatment of Chronic Endometritis (NCT05205993) | Genesis Athens Clinic | 2021-01-19 |
| Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities (NCT04667416) | Amnio Technology, LLC | 2021-01-19 |
| Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis) (NCT04721795) | Obafemi Awolowo University Teaching Hospital | 2021-01-19 |
| ENCOrafenib With Binimetinib in bRAF NSCLC (NCT04526782) | Intergroupe Francophone de Cancerologie Thoracique | 2021-01-19 |
| Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma (NCT04143984) | Shanghai Proton and Heavy Ion Center | 2021-01-19 |
| Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT04655755) | M.D. Anderson Cancer Center | 2021-01-19 |
| Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia (NCT04311307) | University Medical Center Groningen | 2021-01-19 |
| Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients (NCT04529278) | Fondation Hôpital Saint-Joseph | 2021-01-18 |
| Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO) (NCT04712344) | University of Erlangen-Nürnberg Medical School | 2021-01-18 |
| Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study (NCT04589845) | Hoffmann-La Roche | 2021-01-18 |
| Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer (NCT04091022) | University of Alabama at Birmingham | 2021-01-18 |
| Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance (NCT04230499) | Rapamycin Holdings Inc. | 2021-01-18 |
| Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis (NCT04753034) | Teres Bio, Inc. | 2021-01-18 |
| Angiotensin 1-7 as a Therapy in the Treatment of COVID-19 (NCT04605887) | Rambam Health Care Campus | 2021-01-18 |
| Cholecalciferol on Depressive Symptoms in Type 2 Diabetes Mellitus Patients (NCT04917458) | Indonesia University | 2021-01-18 |
| Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT04665765) | City of Hope Medical Center | 2021-01-18 |
| Analgesia for Thyroidectomy Using Bilateral Superficial Cervical Plexus Block With Bupivacaine Only or Adding Ketorolac to it. (NCT05180214) | Sohag University | 2021-01-17 |
| Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients (NCT05132972) | Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia | 2021-01-17 |
| Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients (NCT04049630) | Programme National de Lutte contre l'Onchocercose, Republic of the Congo | 2021-01-16 |
| Fluvoxamine for Adults With Mild to Moderate COVID-19 (NCT04711863) | Asan Medical Center | 2021-01-16 |
| Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC (NCT04547153) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-01-15 |
| Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction (NCT04695990) | Jun Li | 2021-01-15 |
| Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (NCT04693637) | AlloVir | 2021-01-15 |
| Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer (NCT04705909) | Mansoura University | 2021-01-15 |
| COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults (NCT05950776) | Universitätsklinikum Hamburg-Eppendorf | 2021-01-15 |
| Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma (NCT04590664) | Emory University | 2021-01-15 |
| Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC (NCT04890392) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-01-15 |
| Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients (NCT04673422) | Phramongkutklao College of Medicine and Hospital | 2021-01-15 |
| Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia (NCT05851027) | Qilu Pharmaceutical Co., Ltd. | 2021-01-15 |